By Dani Kass ( January 4, 2017, 3:24 PM EST) -- A potential class of Allergan PLC shareholders on Tuesday told a New York federal court that the drugmaker and its executives failed to disclose that they were part of a scheme to rig generic drug prices, leading to a plunge when it was announced the U.S. Department of Justice had launched an investigation....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.